APDN Announces Selected Preliminary Unaudited Fiscal 4th Quarter and Year End Results

STONY BROOK, N.Y. (December 15, 2017) - Applied DNA Sciences, Inc. (NASDAQ: APDN; “Applied DNA”) today announced selected preliminary unaudited financial results for the full fiscal year and quarter ended September 30, 2017. Preliminary (Unaudited) Fiscal 2017 Financial Results: Revenues increased 13% to $4.8 million as compared to $4.2 million in the prior fiscal year. [...]